Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
enGene Holdings Inc. | Director | Common Shares | 239K | $2.39M | $10.00 | Feb 20, 2024 | Indirect |
enGene Holdings Inc. | Director | Warrants (right to buy) | 20.7K | Oct 31, 2023 | Indirect | ||
enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENGN | enGene Holdings Inc. | Jun 15, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
ENGN | enGene Holdings Inc. | Feb 20, 2024 | 2 | $8M | 4 | Feb 21, 2024 | Director, 10%+ Owner |
ENGN | enGene Holdings Inc. | Oct 31, 2023 | 12 | $0 | 4 | Nov 2, 2023 | Director, 10%+ Owner |
ENGN | enGene Holdings Inc. | Oct 31, 2023 | 0 | $0 | 3 | Oct 31, 2023 | Director |
LVAC | LAVA Medtech Acquisition Corp. | Oct 26, 2021 | 0 | $0 | 3 | Oct 26, 2021 | President, Director |